Skip to main content
JUBILANT PHARMOVA LIMITED logo

JUBILANT PHARMOVA LIMITED — Investor Relations & Filings

Ticker · JUBLPHARMA ISIN · INE700A01033 LEI · 335800C6LDKWF4HQH833 BSE.NS Manufacturing
Open in API
Filings indexed 1,045 across all filing types
Latest filing 2022-04-13 Regulatory Filings
Country IN India
Listing BSE.NS JUBLPHARMA

About JUBILANT PHARMOVA LIMITED

https://www.jubilantpharmova.com/

Jubilant Pharmova Limited is an integrated global pharmaceutical company operating through three primary segments: Pharmaceuticals, Contract Research and Development Services (CRDS), and Proprietary Novel Drugs. The Pharmaceuticals segment specializes in radiopharmaceuticals for nuclear medicine, allergy immunotherapy, and the development and manufacturing of generic formulations. It also provides Contract Development and Manufacturing Organization (CDMO) services for sterile injectables and non-sterile products. The CRDS division offers comprehensive drug discovery and development solutions to biopharmaceutical companies worldwide. Furthermore, the Proprietary Novel Drugs segment focuses on creating innovative therapies for oncology and autoimmune diseases. The company leverages its advanced manufacturing infrastructure and research capabilities to serve global markets with a focus on complex chemistry and specialized healthcare solutions.

Recent filings

Filing Released Lang Actions
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of a share certificate by a shareholder and the request for issuance of a duplicate certificate. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about a specific share certificate issue, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. It is a regulatory announcement related to shareholding records and compliance with listing obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-04-13 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of physical share certificates for the quarter ended March 31, 2022. It is a compliance certificate issued by the Registrar and Share Transfer Agent to the company and stock exchanges. The document is short (2374 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of voting results, board changes, or capital changes. It is a regulatory filing related to securities regulations and compliance. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-04-12 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges and the registrar regarding the loss of share certificates by a shareholder. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and issuance of duplicates. The content is about notifying the exchange and requesting caution against transactions in the lost shares. There are no financial statements, earnings data, or management discussion. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital update. The document is a regulatory notification related to share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other categories.
2022-04-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation Classification · 95% confidence The document is a detailed investor presentation dated April 4, 2022, addressed to stock exchanges and investors/analysts. It includes business overviews, management team details, business structure, market segments, growth outlooks, and strategic information. The text explicitly mentions "Investor Presentation February 2022" and contains forward-looking statements, business snapshots, and operational highlights typical of investor presentations. There is no indication that this is a full annual or quarterly report, audit report, earnings release, or regulatory filing. The document is lengthy (15,000 characters) and contains substantive content rather than just an announcement or certification. Therefore, the document fits the category of an Investor Presentation (IP).
2022-04-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the cancellation of an investors/analysts meeting scheduled for April 5, 2022. It is a notification or update rather than a financial report or detailed presentation. The document length is only 830 characters, indicating it is a brief announcement. There is no financial data, no detailed report, no voting results, no management changes, or other substantive content. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-04-05 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is titled 'Regulation 31(4)- Annual Declar' and contains a table listing entities/persons categorized as 'Promoter' or 'Promoter Group' for Jubilant Pharmova Limited with a financial year end of 31-Mar-2022. Regulation 31(4) typically relates to disclosures of shareholding or promoter holdings. The document is short (2411 characters) and consists mainly of a list of shareholders or promoter entities. It does not contain financial statements, management discussion, or detailed report content. This type of document aligns with a Major Shareholding Notification, which reports changes or status of significant share ownership levels, especially for promoters. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2022-04-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.